Search
Mar 21
William Blair's Andy Hsieh returns to Analyst Thursdays to talk radiopharma buyouts, obesity and more
Andy Hsieh gives his take on the radiopharmaceutical space, Viking’s obesity data, Pyxis Oncology, Cardiff Oncology, Fibrogen.
Nov 30, 2023
William Blair Senior Biotech Analyst Andy Hsieh joins Analyst Thursdays from the Bay Area
Andy Hsieh comments on AbbVie's buyout of ImmunoGen, gives a deep dive into radiopharmaceutical, and discusses AASLD, Seagen, and Icosavax.
Sep 28, 2023
William Blair’s Andy Hsieh joins BiotechTV for Analyst Thursdays
William Blair’s Andy Hsieh discusses recent data from CymaBay, and comments on Madrigal, Viking, Exelixis, POINT, Fusion, and Icosavax.
.png){kind=logo}
